shRNA沉默<em>Sp1</em>对胶质瘤细胞放射敏感性的影响

doi:10.3760/cma.j.cn113030-20210518-00196

摘要
图/表
参考文献(0)
相关文章 (15)
点击分布统计
下载分布统计

全文: PDF (0 KB) HTML (1 KB)
输出: BibTeX | EndNote (RIS) 背景资料

摘要目的探讨下调Sp1基因表达对胶质瘤细胞放射敏感性的影响。方法设计并合成编码shRNA的寡核苷酸序列,克隆入LV3（H1/GFP&Puro）载体中构建重组体。然后重组慢病毒分别感染U251和U87细胞,嘌呤霉素筛选得到稳定转染细胞株。荧光定量RT-PCR和蛋白质印迹法分别检测细胞中Sp1 mRNA和蛋白表达水平;克隆存活法检测细胞存活;流式法检测细胞周期;免疫荧光法检测DNA损伤程度。结果两株胶质瘤细胞在感染72 h后荧光显微镜观察Sp1慢病毒载体均高表达,RT-PCR和蛋白质印迹法结果显示转染后shRNA-U87和shRNA-U251细胞Sp1 mRMA和蛋白表达量均明显降低（P<0.01）,Sp1敲除率达90%以上。shRNA-U251和shRNA-U87细胞在10%细胞存活水平下的放射增敏比（SER）分别为1.39和1.18;两株Sp1敲除组细胞经辐照后G₂/M期比率及γ-H2AX foci数目与对照组相比均极显著增大。结论 shRNA沉默Sp1增大了X线诱导的G₂/M期阻滞,加重了DNA双链断裂程度,提高了胶质瘤细胞的放射敏感性。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	王琦琦
	曾家豫
	李强
	刘雄雄

关键词 ： shRNA沉默, Sp1基因, 胶质瘤细胞, 放射敏感性

Abstract：Objective To evaluate the effect of down-regulation of Sp1 expression on the radiosensitivity of glioma cells. Methods The oligonucleotide sequence encoding shRNA was designed and synthesized, and cloned into LV3 (H1/GFP & Puro) vector to construct the recombinant. U251 and U87 cells were infected with recombinant lentivirus, then the stably-transfected cell lines were obtained by puromycin screening. The expression levels of Sp1 mRNA and protein were detected by RT-PCR and Western blot. Cell survival was detected by clonal survival assay, cell cycle was determined by flow cytometry, and DNA damage was measured by immunofluorescence assay, respectively. Results At 72 h after infection, high expression of Sp1 lentiviral vector was observed in two cell lines under fluorescence microscope. RT-PCR and Western blot confirmed that the expression levels of Sp1 mRNA and protein were significantly down-regulated in both transfected cells (both P<0.01) and the silencing rates of Sp1 were above 90%. The sensitization enhancement ratio (SER) of shRNA-U251 and shRNA-U87 cells at 10% cell survival level were 1.39 and 1.18, respectively. After irradiation, the G₂/M phase ratio and the number of γ-H2AX foci in two Sp1 knockout groups were significantly increased. Conclusions hRNA silencing of Sp1 increases the G₂/M phase arrest induced by X-ray, aggravates the degree of DNA double-strand breaks, and improves the radiosensitivity of glioma cells.

Key words： shRNA silencing Sp1 Glioma cell Radiosensitivity

收稿日期: 2021-05-18

ZTFLH:

基金资助:甘肃省自然科学基金（21JR7RA097）; 陇原青年创新创业人才项目（2021LQGR63）

通讯作者: 刘雄雄,Email： lxx002@impcas.ac.cn

引用本文:

王琦琦,曾家豫,李强等. shRNA沉默Sp1对胶质瘤细胞放射敏感性的影响[J]. 中华放射肿瘤学杂志, 2022, 31(7): 638-642.

Wang Qiqi,Zeng Jiayu,Li Qiang et al. Effect of shRNA silencing of Sp1on radiosensitivity of glioma cells[J]. Chinese Journal of Radiation Oncology, 2022, 31(7): 638-642.

链接本文:

http://journal12.magtechjournal.com/Jweb_fszlx/CN/10.3760/cma.j.cn113030-20210518-00196 或 http://journal12.magtechjournal.com/Jweb_fszlx/CN/Y2022/V31/I7/638

[1] Kaczynski J, Cook T, Urrutia R.Sp1- and krüppel-like transcription factors[J]. Genome Biol, 2003, 4(2):206. DOI: 10.1186/gb-2003-4-2-206.
[2] Luo J, Wang X, Xia Z, et al.Transcriptional factor specificity protein 1 (Sp1) promotes the proliferation of glioma cells by up-regulating midkine (MDK)[J]. Mol Biol Cell, 2015, 26(3):430-439. DOI: 10.1091/mbc.E14-10-1443.
[3] Beishline K, Azizkhan-Clifford J.Sp1 and the 'hallmarks of cancer'[J]. FEBS J, 2015, 282(2):224-258. DOI: 10.1111/febs.13148.
[4] Guan H, Cai J, Zhang N, et al.Sp1 is upregulated in human glioma, promotes MMP-2-mediated cell invasion and predicts poor clinical outcome[J]. Int J Cancer, 2012, 130(3):593-601. DOI: 10.1002/ijc.26049.
[5] Nishida Y, Mizutani N, Inoue M, et al.Phosphorylated Sp1 is the regulator of DNA-PKcs and DNA ligase IV transcription of daunorubicin-resistant leukemia cell lines[J]. Biochim Biophys Acta, 2014, 1839(4):265-274. DOI: 10.1016/j.bbagrm.2014.02.004.
[6] Gjyshi O, Liao Z.Proton therapy for locally advanced non-small cell lung cancer[J]. Br J Radiol, 2020, 93(1107):20190378. DOI: 10.1259/bjr.20190378.
[7] Beishline K, Kelly CM, Olofsson BA, et al.Sp1 facilitates DNA double-strand break repair through a nontranscriptional mechanism[J]. Mol Cell Biol, 2012, 32(18):3790-3799. DOI: 10.1128/MCB.00049-12.
[8] Fletcher SC, Grou CP, Legrand AJ, et al.Sp1 phosphorylation by ATM downregulates BER and promotes cell elimination in response to persistent DNA damage[J]. Nucleic Acids Res, 2018, 46(4):1834-1846. DOI: 10.1093/nar/gkx1291.
[9] 刘雄雄. 金雀异黄酮的辐射增敏作用及机理研究[D]. 兰州:中国科学院研究生院(近代物理研究所), 2014.
Liu XX.Study on the radiosensitizating effects of genistein and corresponding mechanisms [D]. Lanzhou: University of Chinese Academy of Sciences (Institute of Modern Physics), 2014.
[10] Redon CE, Dickey JS, Bonner WM, et al.γ-H2AX as a biomarker of DNA damage induced by ionizing radiation in human peripheral blood lymphocytes and artificial skin[J]. Adv Space Res, 2009, 43(8):1171-1178. DOI: 10.1016/j.asr.2008.10.011.
[11] 王晓冰, 彭伟强, 易智君, 等. 转录因子Sp1在乳腺癌组织中的表达及其预后意义[J]. 癌症, 2007, 26(9): 996-1000. DOI: 10.3969/j.issn.1000- 467X.2007.09.014.
Wang XB, Peng WQ, Yi ZJ, et al.Expression and prognostic value of transcriptional factor Sp1 in breast cancer[J]. Chin J Cancer,2007,26(9):996-1000. DOI: 10.3969/j.issn.1000- 467X.2007.09.014.
[12] Deng YR, Chen XJ, Chen W, et al.Sp1 contributes to radioresistance of cervical cancer through targeting G2/M cell cycle checkpoint CDK1[J]. Cancer Manag Res, 2019, 11:5835-5844. DOI: 10.2147/CMAR.S200907.
[13] Wang J, Kang M, Wen Q, et al.Berberine sensitizes nasopharyngeal carcinoma cells to radiation through inhibition of Sp1 and EMT[J]. Oncol Rep, 2017, 37(4):2425-2432. DOI: 10.3892/or.2017.5499.
[14] Chen YT, Tsai HP, Wu CC, et al.High-level Sp1 is associated with proliferation, invasion, and poor prognosis in astrocytoma[J]. Pathol Oncol Res, 2019, 25(3):1003-1013. DOI: 10.1007/s12253-018-0422-8.
[15] Tao S, Meng S, Zheng X, et al.ATM participates in the regulation of viability and cell cycle via ellipticine in bladder cancer[J]. Mol Med Rep, 2017, 15(3):1143-1148. DOI: 10.3892/mmr.2017.6141.
[16] Zhang S, Lu J, Zhao X, et al.A variant in the CHEK2 promoter at a methylation site relieves transcriptional repression and confers reduced risk of lung cancer[J]. Carcinogenesis, 2010, 31(7):1251-1258. DOI: 10.1093/carcin/bgq089.
[17] Tapias A, Ciudad CJ, Roninson IB, et al.Regulation of Sp1 by cell cycle related proteins[J]. Cell Cycle, 2008, 7(18):2856-2867. DOI: 10.4161/cc.7.18.6671.
[18] Shahrabani-Gargir L, Pandita TK, Werner H.Ataxia-telangiectasia mutated gene controls insulin-like growth factor I receptor gene expression in a deoxyribonucleic acid damage response pathway via mechanisms involving zinc-finger transcription factors Sp1 and WT1[J]. Endocrinology, 2004, 145(12):5679-5687. DOI: 10.1210/en.2004-0613.
[19] Gueven N, Keating K, Fukao T, et al.Site-directed mutagenesis of the ATM promoter: consequences for response to proliferation and ionizing radiation[J]. Genes Chromosomes Cancer, 2003, 38(2):157-167. DOI: 10.1002/gcc.10261.
[20] Keating KE, Gueven N, Watters D, et al.Transcriptional downregulation of ATM by EGF is defective in ataxia-telangiectasia cells expressing mutant protein[J]. Oncogene, 2001, 20(32):4281-4290. DOI: 10.1038/sj.onc.1204527.
[21] Hosoi Y, Watanabe T, Nakagawa K, et al.Up-regulation of DNA-dependent protein kinase activity and Sp1 in colorectal cancer[J]. Int J Oncol, 2004, 25(2):461-468.